Ianiotescu Stelian, Gingu Constantin, Balescu Irina, Bacalbasa Nicolae, Sinescu Ioanel
Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Center of Uronephrology and Kidney Transplantation, Fundeni Clinical Institute, Bucharest, Romania.
J Med Life. 2025 Apr;18(4):393-396. doi: 10.25122/jml-2025-0059.
We report the case of a 58-year-old male with metachronous renal tumors and a solitary kidney who had previously undergone an open right radical nephrectomy with extended lymphadenectomy for an invasive renal cell carcinoma (RCC) (pT3a N0M0) in November 2013. In May 2022, during routine surveillance, a left lower pole lesion measuring 2.5 × 2 × 1.6 cm was detected, and the patient was submitted to robot-assisted partial nephrectomy (RAPN). The histopathological study confirmed the presence of a pT1a Fuhrman grade 3 clear cell renal carcinoma. In October 2024, follow-up imaging revealed a new upper pole lesion measuring 4 × 3 × 2.3 cm in the left kidney. The patient was submitted to a novel robot-assisted partial nephrectomy, which was successfully completed using selective clamping of the renal artery. The clamping time was 28 minutes (versus 17 minutes during the initial procedure), and the estimated blood loss increased to approximately 300 mL compared to about 100 mL previously, with a console time of 98 minutes. The patient was discharged after the second surgery in good functional status. The final pathology revealed clear cell RCC, Fuhrman grade 2/nucleolar grade 2 (WHO/ISUP 2016), and pT1a, with negative margins. Despite increased technical challenges during reoperation, postoperative renal function remained stable, underscoring the feasibility of repeat RAPN in a solitary kidney.
我们报告了一例58岁男性患者,患有异时性肾肿瘤且为单肾,该患者曾于2013年11月因侵袭性肾细胞癌(RCC)(pT3a N0M0)接受开放性右根治性肾切除术及扩大淋巴结清扫术。2022年5月,在常规监测期间,发现左肾下极有一个大小为2.5×2×1.6 cm的病灶,患者接受了机器人辅助部分肾切除术(RAPN)。组织病理学研究证实为pT1a级富尔曼3级透明细胞肾 carcinoma。2024年10月,随访影像学检查发现左肾出现一个新的上极病灶,大小为4×3×2.3 cm。患者接受了一次新的机器人辅助部分肾切除术,通过选择性夹闭肾动脉成功完成手术。夹闭时间为28分钟(与初次手术时的17分钟相比),估计失血量增至约300 mL,而之前约为100 mL,手术控制台操作时间为98分钟。患者在第二次手术后功能状态良好出院。最终病理显示为透明细胞RCC,富尔曼2级/核仁2级(WHO/ISUP 2016),pT1a,切缘阴性。尽管再次手术时技术挑战增加,但术后肾功能保持稳定,这突出了在单肾患者中重复进行RAPN的可行性。